The purpose of the current study was to determine the effects of vascular e
ndothelial growth factor (VEGF) on muscle flap survival and vascularity in
a rat gracilis ischemia-reperfusion model. A total of 12 adult male Wistar
rats were divided into two groups (n = 6). The experimental group received
the plasmid encoding VEGF(165) cDNA plus lipofectamine (cationic liposome)
injected directly to the gracilis muscle following 4 h of ischemia. The con
trol group received lipofectamine only. The viability and vascularity of th
e flaps were evaluated after 7 days of reperfusion. The data demonstrated t
hat the VEGF plasmid- and lipofectamine-treated muscle flaps had significan
tly greater total survival and capillary count 7 days after reperfusion com
pared with the flaps treated only with lipofectamine. These results indicat
e that VEGF exerts a protective effect on ischemic skeletal muscle flaps. (
C) 2001 Wiley-Liss, Inc.